Thursday, 02 April 2020

China News

  • Golden Meditech interim revenue up by 6.4%

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

    Singapore: Golden Meditech, a leading integrated healthcare enterprise in China, revealed its interim results for the six months ending 30 September 2012. During the interim period, the gro...Read more

  • How well is the industry prepared to fight H7N9 bird flu?

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 14 May, 2013

    During March 2013, the world woke up to yet another dreaded bird flu attack that infected humans through poultry. Two months have gone by and biopharma majors across the world have begun pr...Read more

  • GSK China VP confesses in bribery scandal

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

    Singapore: A day after Chinese police made the names of those involved in one of the country's biggest scandal involving a major pharmaceutical company public, GlaxoSmithKline China's vice ...Read more

  • China prepares to get its first national biobank

    China |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2013

    Singapore: BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, through its partnership with BGI-Shenzhen, plans to provide t...Read more

  • Complete Genomics, Illumina settle all patent suits

    China |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: Complete Genomics, a wholly-owned subsidiary of China-based BGI-Shenzhen, entered into a settlement agreement with Illumina, under which the later will dismiss with prejudice bot...Read more

  • Welichem pays $9 mn for anti-inflammatory agent

    China |  News | By BioSpectrum Bureau  | 0 Comment | 29 Mar, 2013

    Singapore: Welichem Biotech entered into an asset purchase agreement to buy the exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in China, ...Read more

  • Dr Ling Su joins Sidley Austin as advisor in China life sciences practice

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2012

    Singapore: Dr Ling Su, a non-lawyer and a seasoned drug development professional, has joined law firm Sidley Austin as a strategic advisor in its China life sciences practice. Dr Su was rec...Read more

  • Neusoft to acquire 25% equities in Philips JV

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    ‎Singapore: China based IT solution and Neusoft wholly owned subsidiary, Neusoft Medical Systems has signed agreements with Royal Philips Electronics on the equities and assets transf...Read more

  • Covidien opens $45 million R&D facility in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2012

    Singapore: Covidien, a leading global provider of healthcare products, has opened its China Technology Center (CTC) Research and Development (R&D) facility in Shanghai. "Establishing th...Read more

  • Sigma Aldrich expands presence in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

    Singapore: Sigma-Aldrich launched a redesigned website for China (www.sigmaaldrich.com/china), which will offer more relevant content, improved search results, enhanced product detail pages...Read more

  • Novartis China surrounded by bribery allegations

    China |  News | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2013

    Singapore: Even as Big Pharma in China is surrounded by bribery allegations and investigations were just initiated against French drug maker Sanofi in the country, yet another scandal is un...Read more

  • GSK hit by more bribery allegations in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    Singapore: Days after a probe was initiated by the Chinese police into alleged 'economic crimes' committed by senior officials of GlaxoSmithKline in China, a latest news report has now rele...Read more

  • BSA-CMR Survey: India, China lead in APAC CRO sector

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Yaskawa Electric invests in ReWalk exoskeleton

    China |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2013

    Singapore: Israel-based ARGO Medical Technologies has partnered with innovative robotics experts Yaskawa Electric, Japan, as it continues the global expansion of its ReWalk exoskeleton devi...Read more

  • Osteoporosis is an emerging crisis in APAC: Report

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2013

    Singapore: A new report, launched by the International Osteoporosis Foundation (IOF), shows that osteoporosis is a looming crisis throughout the Asia Pacific, with the number of fracture su...Read more

  • Phillips-Medisize acquires Adval Tech plants in China, Mexico

    China |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2013

    Singapore: US-based Phillips-Medisize has entered into a definitive agreement with the Adval Tech to purchase, for an undisclosed amount, two manufacturing operations: Adval Tech Medical (S...Read more

  • Medicago, tobacco giant in vaccine deal for China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Medicago has granted Philip Morris Products (PMP) an exclusive license to develop, commercialize and manufacture Medicago's pandemic and seasonal influenza vaccines for China. PM...Read more

  • China Nuokang Bio-Pharmaceutical reveals Q1 2012 results

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 24 May, 2012

    Singapore: China Nuokang Bio-Pharmaceutical, a leading China-based biopharmaceutical company focused on the R&D, manufacture, marketing and sales of hospital-based medical products, rev...Read more